Description
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
Cas No. | 639052-78-1 |
---|---|
Purity | ≥98% |
Formula | C16H13ClN2OS |
Formula Wt. | 316.80 |
IUPAC Name | N-(5-Chloro-6-methyl-1,3-benzothiazol-2-yl)-2-phenylacetamide |
Solubility | 100mM in DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Lee JW, Hirota T, Peters EC, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10608-11. PMID: 21954091.
Prodrug
IGF-1R and InsR inhibitor.
Proton pump inhibitor
Broad-spectrum antibiotic
HEXIM1 activator.
Benzoylurea, insect growth regulator; chitin sy...
FIASMA, σ1, RyR2, TrkA/B agonist; SERT, NET in...
Organoselenium compound found in selenium-enric...
Nucleoside (thymidine) analog; DNA chain termin...
Wnt/beta-catenin/CBP inhibitor
L-type and T-type Ca2+ and TRP antagonist.
Curcumin derivative.
Steroidal alkaloid found in Veratrum and Fritil...
Chalcone kavalactone that suppresses inflammati...
Fluoroquinolone; topoisomerase IV and bacterial...
Macrocycle
BRD binding agent, CDK1/2/5/9 inhibitor.
JAK2 inhibitor.
Epoxomicin analog; proteasome inhibitor.
Morpholine derivative.